Insider purchase ignites trader interest: Social media users highlighted a substantial open-market buy by a 10% owner, OrbiMed Advisors LLC, who acquired 597,729 shares worth nearly $1 million at $1.67 amid shares trading around $1.21.
Technical resistance draws scrutiny: Traders pointed to key resistance at $1.44 on charts, suggesting a potential breakout if momentum builds.
Pipeline potential fuels optimism: Conversations referenced the company's oral therapies targeting respiratory viruses like influenza and COVID-19, alongside cancer candidates, in promising markets.
Note: This discussion summary was generated from an AI condensation of post data.
Traws Pharma Insider Trading Activity
Traws Pharma insiders have traded $TRAW stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $TRAW stock by insiders over the last 6 months:
- ADVISORS LLC ORBIMED purchased 597,729 shares for an estimated $998,207
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
Traws Pharma Hedge Fund Activity
We have seen 11 institutional investors add shares of Traws Pharma stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- IKARIAN CAPITAL, LLC added 649,649 shares (+2280.0%) to their portfolio in Q4 2025, for an estimated $734,103
- BOOTHBAY FUND MANAGEMENT, LLC added 194,536 shares (+inf%) to their portfolio in Q4 2025, for an estimated $219,825
- ADAR1 CAPITAL MANAGEMENT, LLC added 154,431 shares (+inf%) to their portfolio in Q4 2025, for an estimated $174,507
- VESTAL POINT CAPITAL, LP removed 150,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $169,499
- XTX TOPCO LTD added 31,502 shares (+294.2%) to their portfolio in Q4 2025, for an estimated $35,597
- STATE STREET CORP added 25,802 shares (+inf%) to their portfolio in Q4 2025, for an estimated $29,156
- CITADEL ADVISORS LLC added 24,819 shares (+inf%) to their portfolio in Q4 2025, for an estimated $28,045
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
